Back to search
FDAFDA · Food and drugs·Recall number D-0306-2025

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13

Published April 9, 2025 · Recall initiated: March 17, 2025

Summary

FDA records drug Class II recall D-0306-2025, published April 9, 2025 and initiated March 17, 2025. Recalling firm: BIOCON PHARMA INC; Status: Ongoing; Reported quantity: 2184 bottles; Lot: Lot#: AVC24035, Exp 03/31/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications: lower than specifications

What to do

Voluntary: Firm initiated

Get an email if ATORVASTATIN CALCIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATORVASTATIN CALCIUM
Manufacturer
BIOCON PHARMA INC
Distributor
U.S.A. nationwide
UPC
0370377080111
Lot
Lot#: AVC24035, Exp 03/31/26
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13 recalled?

Yes. FDA published recall D-0306-2025 on April 9, 2025. Reported hazard: Failed dissolution specifications: lower than specifications

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0370377080111.